Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBunzl Regulatory News (BNZL)

Share Price Information for Bunzl (BNZL)

Share Price is delayed by 15 minutes
Get Live Data
2,438.00    48.00 (2.01%)
Bid:
2,438.00
Ask:
2,442.00
Spread: 4.00 (0.164%)
Market Cap: £7.83b
BNZL Live PriceLast checked at - London Stock Exchange

Intraday Bunzl Share Chart

Trading Statement

28 Jun 2017 07:00

RNS Number : 3282J
Bunzl PLC
28 June 2017
 

28 June 2017

 

BUNZL PRE CLOSE STATEMENT AND

ACQUISITIONS IN SPAIN AND CANADA

 

Bunzl plc, the international distribution and outsourcing Group, is updating the market today relating to the six months ending 30 June 2017 prior to entering its closed period.

 

Overall trading is consistent with expectations at the time of the first quarter trading statement in April. Group revenue for the half year is expected to have increased by 7% at constant exchange rates due to the improved underlying growth of between 3% and 4% and a similar impact from acquisitions. In addition, currency translation movements are expected to have increased the constant exchange revenue growth by 12%. As previously indicated, the underlying revenue growth is mainly due to the additional business won, albeit at lower margins, in North America towards the end of 2016.

 

Acquisitions continue to be an important part of the Company's strategy for growth and Bunzl also today announces that it has purchased three further businesses in Spain and Canada.

 

Tecnopacking, which is based near Valencia, is engaged in the distribution of industrial and disposable packaging products to end users operating in a variety of different sectors throughout Spain as well as in Portugal. Revenue in 2016 was €38 million.

 

Bunzl has also acquired two separate businesses in Canada. AMFAS and Western Safety, which are both based in Vancouver, are distributors of commercial and industrial first aid and safety supplies, including a full range of personal protection equipment, to end user customers throughout Western Canada. The businesses, which together have aggregated annualised revenue of C$16 million, also provide safety-related services including training programmes and other workplace safety solutions.

 

Bunzl has now acquired eight businesses so far this year for a total committed spend of approximately £290 million, adding aggregate annualised revenue of £370 million. With an active acquisition pipeline and ongoing discussions taking place, the Company expects to complete further acquisitions during the remainder of the year.

 

Commenting on the acquisitions, Frank van Zanten, Chief Executive of Bunzl said:

 

"The acquisition of Tecnopacking has further extended our operations in Spain which have grown significantly in recent years with total annualised revenue now approaching €200 million. We have also seen rapid growth in Canada with the purchase of AMFAS and Western Safety bringing the total number of businesses acquired there since the beginning of 2015 to nine. We are delighted to welcome all of their employees to the Group.

 

I am particularly pleased to see that the level of acquisition activity has picked up this year with the purchase of a number of high quality businesses which have allowed us to expand the Group further. With a promising pipeline of additional opportunities, I would expect us to complete further acquisitions as the year progresses."

 

Enquiries:

 

Bunzl plc

Frank van Zanten, Chief Executive

Brian May, Finance Director

Tel: +44 (0)20 7725 5000

Tulchan

David Allchurch

Martin Robinson

Tel: +44 (0)20 7353 4200

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBXGDLGUDBGRR
Date   Source Headline
27th Aug 20257:00 amRNSTransaction in Own Shares
26th Aug 202510:00 amRNSDividend Declaration
26th Aug 20257:00 amRNSAcquisition
26th Aug 20257:00 amRNSHalf-year Report
5th Aug 20254:25 pmRNSDirector/PDMR Shareholding
1st Aug 20251:01 pmRNSTotal Voting Rights
11th Jul 20255:13 pmRNSDirector/PDMR Shareholding
9th Jul 20255:42 pmRNSDirector/PDMR Shareholding
3rd Jul 20259:24 amRNSDirector/PDMR Shareholding
1st Jul 20254:07 pmRNSDirector/PDMR Shareholding
1st Jul 20254:07 pmRNSTotal Voting Rights
24th Jun 202512:01 pmRNSDirector/PDMR Shareholding
24th Jun 20257:00 amRNSTrading Statement
18th Jun 20254:47 pmRNSDirector/PDMR Shareholding
5th Jun 20252:25 pmRNSDirector/PDMR Shareholding
2nd Jun 202511:19 amRNSTotal Voting Rights
23rd May 20254:55 pmRNSDirector/PDMR Shareholding
19th May 202512:41 pmRNSDirector/PDMR Shareholding
8th May 20252:38 pmRNSDirector/PDMR Shareholding
7th May 202510:00 amRNSDirector/PDMR Shareholding
7th May 20259:58 amRNSDirector/PDMR Shareholding
6th May 20254:06 pmRNSDirector/PDMR Shareholding
1st May 20253:00 pmRNSBlock listing Interim Review
1st May 20259:42 amRNSTotal Voting Rights
1st May 20258:00 amRNSAdditional Listing
30th Apr 20257:00 amRNSAcquisition
28th Apr 202512:00 pmRNSDirector/PDMR Shareholding
24th Apr 20254:56 pmRNSDirector/PDMR Shareholding
23rd Apr 20255:08 pmRNSDirector/PDMR Shareholding
23rd Apr 20254:35 pmRNSResult of AGM
22nd Apr 202511:19 amRNSDirector/PDMR Shareholding
17th Apr 20254:00 pmRNSDirector/PDMR Shareholding
16th Apr 20258:00 amRNSAdditional Listing
16th Apr 20257:00 amRNSTrading Statement
16th Apr 20257:00 amRNSTransaction in Own Shares
15th Apr 20257:00 amRNSTransaction in Own Shares
14th Apr 20257:00 amRNSTransaction in Own Shares
11th Apr 20255:35 pmRNSDirector/PDMR Shareholding
11th Apr 20257:00 amRNSTransaction in Own Shares
10th Apr 20257:00 amRNSTransaction in Own Shares
9th Apr 20257:00 amRNSTransaction in Own Shares
8th Apr 20257:00 amRNSTransaction in Own Shares
7th Apr 20257:00 amRNSTransaction in Own Shares
4th Apr 20257:00 amRNSTransaction in Own Shares
3rd Apr 20254:46 pmRNSDirector/PDMR Shareholding
3rd Apr 20257:00 amRNSTransaction in Own Shares
2nd Apr 20253:56 pmRNSDirector/PDMR Shareholding
2nd Apr 20257:00 amRNSTransaction in Own Shares
1st Apr 20251:47 pmRNSTotal Voting Rights
1st Apr 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.